Peter Meyers, DO
Internal Medicine · Canton, MINPI 1588661771
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $97 of the $113 with a category attached, or 86.3%. Novo Nordisk accounts for 86.3% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for internal medicine clinicians in MI, where the typical reported total is $183.
Across 2 payments — averaging $56.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$97
- AstraZeneca$15
Across 120 payments — averaging $3377.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$287K
- AstraZeneca$62K
- Novo Nordisk AS$42K
- Sanofi US Services Inc.$14K
What the payments were for
- Food & beverage$9786%
- Education$1514%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 1 | $97 |
| AstraZeneca | 1 | $15 |
How this compares
$113 in reported general payments places this provider in the 40th percentile of 4,567 internal medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 123 | $167,808 |
| JardianceEmpagliflozin | 55 | $89,815 |
| OzempicSemaglutide | 61 | $83,846 |
| TrulicityDulaglutide | 36 | $57,409 |
| XareltoRivaroxaban | 22 | $29,513 |
| MounjaroTirzepatide | 24 | $28,821 |
| InvokanaCanagliflozin | 17 | $27,552 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 35 | $25,096 |
| ProliaDenosumab | 13 | $22,266 |
| CreonLipase/Protease/Amylase | 11 | $21,520 |
| Humalog Kwikpen U-100Insulin Lispro | 25 | $11,707 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 70 | $11,322 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $9,483 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 23 | $9,364 |
| SymbicortBudesonide/Formoterol Fumarate | 14 | $9,021 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $97 | $83,84661 claims |
| AstraZenecaSymbicort | $15 | $9,02114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 4,567 internal medicine providers in Michigan.
Other internal medicine in Canton
- Terry SmithAnn Arbor$2.3M
- Michael ValituttoKalamazoo$1.8M
- Ulka VaishampayanAnn Arbor$996K
- Tina AbrahamPontiac$834K
- Steven KatzmanLivonia$715K
- Adam FormanSouthfield$453K
- Saroj NeupaneDetroit$373K
- James BazziDearborn Heights$368K
- Mohamad HatahetWaterford$352K
- A FendrickAnn Arbor$347K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.